129 related articles for article (PubMed ID: 35961053)
1. Prognostic validation of a new classification system for extent of resection in glioblastoma: A report of the RANO resect group.
Karschnia P; Young JS; Dono A; Häni L; Sciortino T; Bruno F; Juenger ST; Teske N; Morshed RA; Haddad AF; Zhang Y; Stoecklein S; Weller M; Vogelbaum MA; Beck J; Tandon N; Hervey-Jumper S; Molinaro AM; Rudà R; Bello L; Schnell O; Esquenazi Y; Ruge MI; Grau SJ; Berger MS; Chang SM; van den Bent M; Tonn JC
Neuro Oncol; 2023 May; 25(5):940-954. PubMed ID: 35961053
[TBL] [Abstract][Full Text] [Related]
2. Supramaximal resection: retrospective study on IDH-wildtype Glioblastomas based on the new RANO-Resect classification.
Tropeano MP; Raspagliesi L; Bono BC; Baram A; Rossini Z; Franzini A; Navarria P; Clerici E; Bellu L; Simonelli M; Scorsetti M; Riva M; Politi LS; Pessina F
Acta Neurochir (Wien); 2024 Apr; 166(1):196. PubMed ID: 38676720
[TBL] [Abstract][Full Text] [Related]
3. Standardized evaluation of the extent of resection in glioblastoma with automated early post-operative segmentation.
Luque L; Skogen K; MacIntosh BJ; Emblem KE; Larsson C; Bouget D; Helland RH; Reinertsen I; Solheim O; Schellhorn T; Vardal J; Mireles EEM; Vik-Mo EO; Bjørnerud A
Front Radiol; 2024; 4():1357341. PubMed ID: 38840717
[TBL] [Abstract][Full Text] [Related]
4. SUPRAMAX-study: supramaximal resection versus maximal resection for glioblastoma patients: study protocol for an international multicentre prospective cohort study (ENCRAM 2201).
Gerritsen JKW; Young JS; Chang SM; Krieg SM; Jungk C; van den Bent MJ; Satoer DD; Ille S; Schucht P; Nahed BV; Broekman MLD; Berger M; De Vleeschouwer S; Vincent AJPE
BMJ Open; 2024 Apr; 14(4):e082274. PubMed ID: 38684246
[TBL] [Abstract][Full Text] [Related]
5. Associations between recurrence patterns and outcome in glioblastoma patients undergoing re-resection: A complementary report of the RANO resect group.
Karschnia P; Dono A; Young JS; Juenger ST; Teske N; Häni L; Sciortino T; Mau CY; Bruno F; Nunez L; Morshed RA; Haddad AF; Weller M; van den Bent M; Thon N; Beck J; Hervey-Jumper S; Molinaro AM; Tandon N; Rudà R; Vogelbaum MA; Bello L; Schnell O; Grau SJ; Chang SM; Berger MS; Esquenazi Y; Tonn JC
Neuro Oncol; 2024 Mar; 26(3):584-586. PubMed ID: 38164632
[No Abstract] [Full Text] [Related]
6. Tumor growth in recurrent glioblastoma-RANO: when to plan the baseline scan?
Dobber L; Geurts M; van den Bent MJ
Neuro Oncol; 2024 Jun; ():. PubMed ID: 38856584
[No Abstract] [Full Text] [Related]
7. Prognostic evaluation of re-resection for recurrent glioblastoma using the novel RANO classification for extent of resection: A report of the RANO resect group.
Karschnia P; Dono A; Young JS; Juenger ST; Teske N; Häni L; Sciortino T; Mau CY; Bruno F; Nunez L; Morshed RA; Haddad AF; Weller M; van den Bent M; Beck J; Hervey-Jumper S; Molinaro AM; Tandon N; Rudà R; Vogelbaum MA; Bello L; Schnell O; Grau SJ; Chang SM; Berger MS; Esquenazi Y; Tonn JC
Neuro Oncol; 2023 Sep; 25(9):1672-1685. PubMed ID: 37253096
[TBL] [Abstract][Full Text] [Related]
8. Glioblastoma and Other Primary Brain Malignancies in Adults: A Review.
Schaff LR; Mellinghoff IK
JAMA; 2023 Feb; 329(7):574-587. PubMed ID: 36809318
[TBL] [Abstract][Full Text] [Related]
9. Vorasidenib and ivosidenib in IDH1-mutant low-grade glioma: a randomized, perioperative phase 1 trial.
Mellinghoff IK; Lu M; Wen PY; Taylor JW; Maher EA; Arrillaga-Romany I; Peters KB; Ellingson BM; Rosenblum MK; Chun S; Le K; Tassinari A; Choe S; Toubouti Y; Schoenfeld S; Pandya SS; Hassan I; Steelman L; Clarke JL; Cloughesy TF
Nat Med; 2023 Mar; 29(3):615-622. PubMed ID: 36823302
[TBL] [Abstract][Full Text] [Related]
10. Histological and molecular classifications of pediatric glioma with time-dependent diffusion MRI-based microstructural mapping.
Zhang H; Liu K; Ba R; Zhang Z; Zhang Y; Chen Y; Gu W; Shen Z; Shu Q; Fu J; Wu D
Neuro Oncol; 2023 Jun; 25(6):1146-1156. PubMed ID: 36617263
[TBL] [Abstract][Full Text] [Related]
11. Deep learning based on preoperative magnetic resonance (MR) images improves the predictive power of survival models in primary spinal cord astrocytomas.
Sun T; Wang Y; Liu X; Li Z; Zhang J; Lu J; Qu L; Haller S; Duan Y; Zhuo Z; Cheng D; Xu X; Jia W; Liu Y
Neuro Oncol; 2023 Jun; 25(6):1157-1165. PubMed ID: 36562243
[TBL] [Abstract][Full Text] [Related]
12. Impact of maximal extent of resection on postoperative deficits, patient functioning, and survival within clinically important glioblastoma subgroups.
Gerritsen JKW; Zwarthoed RH; Kilgallon JL; Nawabi NL; Versyck G; Jessurun CAC; Pruijn KP; Fisher FL; Larivière E; Solie L; Mekary RA; Satoer DD; Schouten JW; Bos EM; Kloet A; Tewarie RN; Smith TR; Dirven CMF; De Vleeschouwer S; Vincent AJPE; Broekman MLD
Neuro Oncol; 2023 May; 25(5):958-972. PubMed ID: 36420703
[TBL] [Abstract][Full Text] [Related]
13. Clinical and molecular features of patients with IDH1 wild-type primary glioblastoma presenting unexpected short-term survival after gross total resection.
Toyoda M; Shibahara I; Shigeeda R; Fujitani K; Tanihata Y; Hyakutake Y; Handa H; Komai H; Sato S; Inukai M; Hide T; Shimoda Y; Kanamori M; Endo H; Saito R; Matsuda KI; Sonoda Y; Kumabe T
J Neurooncol; 2024 Jun; ():. PubMed ID: 38839702
[TBL] [Abstract][Full Text] [Related]
14. L-RNA aptamer-based CXCL12 inhibition combined with radiotherapy in newly-diagnosed glioblastoma: dose escalation of the phase I/II GLORIA trial.
Giordano FA; Layer JP; Leonardelli S; Friker LL; Turiello R; Corvino D; Zeyen T; Schaub C; Müller W; Sperk E; Schmeel LC; Sahm K; Oster C; Kebir S; Hambsch P; Pietsch T; Bisdas S; Platten M; Glas M; Seidel C; Herrlinger U; Hölzel M
Nat Commun; 2024 May; 15(1):4210. PubMed ID: 38806504
[TBL] [Abstract][Full Text] [Related]
15. Speeding up Glioblastoma Cancer Research: Highlighting the Zebrafish Xenograft Model.
Alberti G; Amico MD; Caruso Bavisotto C; Rappa F; Marino Gammazza A; Bucchieri F; Cappello F; Scalia F; Szychlinska MA
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791432
[TBL] [Abstract][Full Text] [Related]
16. Clinical Course after Carmustine Wafer Implantation for Newly Diagnosed Adult-type Diffuse Gliomas; A controlled propensity matched analysis of a single center cohort.
Ono T; Suzuki H; Nanjo H; Shimizu H
J Neurooncol; 2024 May; ():. PubMed ID: 38780714
[TBL] [Abstract][Full Text] [Related]
17. Prognostic relevance of radiological findings on early postoperative MRI for 187 consecutive glioblastoma patients receiving standard therapy.
Rykkje AM; Carlsen JF; Larsen VA; Skjøth-Rasmussen J; Christensen IJ; Nielsen MB; Poulsen HS; Urup TH; Hansen AE
Sci Rep; 2024 May; 14(1):10985. PubMed ID: 38744979
[TBL] [Abstract][Full Text] [Related]
18. Automated online safety margin (GLIOVIS) for glioma surgery model.
Mazevet M; Oberli C; Marinelli S; Zaed I; Bauer S; Kaelin-Lang A; Marchi F; Gardenghi R; Reinert M; Cardia A
Front Oncol; 2024; 14():1361022. PubMed ID: 38741783
[TBL] [Abstract][Full Text] [Related]
19. Comparison of different target volume delineation strategies based on recurrence patterns in adjuvant radiotherapy for glioblastoma.
Yilmaz MT; Kahvecioglu A; Yedekci FY; Yigit E; Ciftci GC; Kertmen N; Zorlu F; Yazici G
Neurooncol Pract; 2024 Jun; 11(3):275-283. PubMed ID: 38737611
[TBL] [Abstract][Full Text] [Related]
20. Glioma.
Weller M; Wen PY; Chang SM; Dirven L; Lim M; Monje M; Reifenberger G
Nat Rev Dis Primers; 2024 May; 10(1):33. PubMed ID: 38724526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
